Catalyst Wire Dossier Catalyst Wire Dossier

Retapamulin (Altabax)

retapamulin · Stiefel, a GSK Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Retapamulin (Altabax), covering 2011-08-26 to 2011-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA [Phase 3]

See pricing